Results 101 to 110 of about 5,351 (253)

Expert Testimony in Child Sexual Abuse Litigation

open access: yes, 1989
I. Introduction II. Admissibility of Expert Testimony ... A. General Rule of Admissibility ... B. Permissible Bases for Expert Testimony ... C. Qualifications of Expert Witnesses ... D. Form of Expert Testimony ... E. The Ultimate Issue Rule III.
Corwin, David L.   +5 more
core  

Developing Transdiagnostic Single‐Session Interventions for University Students Experiencing Disordered Eating: A Mixed‐Method Co‐Design Study

open access: yesInternational Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Many university students encounter barriers to timely support for disordered eating. Brief, scalable digital single‐session interventions (SSIs) may provide an engaging and accessible transdiagnostic pathway for early intervention where there is increased distress before a diagnosis emerges.
Maya Jabs, Tracey D. Wade
wiley   +1 more source

Laudan’s Meta-Rule for Evaluating Evidence and the Case of Expert Testimony

open access: yesQuaestio Facti
This article examines the challenges posed by expert testimony within the context of the US legal system, focusing primarily on the rules of evidence and judicial practices regulating admissibility - most notably Rule 702 of the Federal Rules of ...
Ernesto Saccardi
doaj  

Human Factors Expert Testimony after Daubert (1993)

open access: yes, 1997
This paper reviewed Human Factors expert testimony after the Supreme Court decision in Daubert v. Merrell Dow Pharmaceuticals, Inc. (1993). Daubert (1993) set a new standard for Experts testifying in federal courts.
Gerald V. Barrett, Rafael C. Ortiz
core   +1 more source

Disinformation and misinformation in epilepsy: An analysis of multiplatform short‐form social media video content

open access: yesEpileptic Disorders, EarlyView.
Abstract Objective Short‐form social media content is increasing in popularity but is at risk for propagating health‐related disinformation/misinformation. We aimed to quantify epilepsy‐related disinformation/misinformation on three such platforms: TikTok, Instagram Reels, and YouTube Shorts.
Maggie St‐Pierre   +4 more
wiley   +1 more source

An SSI‐Informed Design for Tuned Mass Dampers With Small‐to‐Large Mass Ratios

open access: yesEarthquake Engineering &Structural Dynamics, EarlyView.
ABSTRACT Tuned Mass Dampers (TMDs) are used to mitigate structural vibrations induced by seismic or wind excitation, by tuning the device to the system's dominant resonant frequencies. However, the TMD effectiveness can be undermined by soil‐structure interaction, which can lead to elongation of the vibration periods and to combined translational ...
Davide Noè Gorini   +3 more
wiley   +1 more source

First‐Line Osimertinib in Patients with EGFR‐Mutant Advanced Non‐Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study

open access: yesThe Oncologist, EarlyView., 2021
Abstract Lessons Learned Osimertinib has confirmed effectiveness in this real‐world population of patients with EGFR‐mutant advanced non‐small cell lung cancer. Thromboembolic events occur more frequently than previously reported, suggesting a thrombotic diathesis that requires further investigation. Patients with at least three metastatic sites, brain
Martina Lorenzi   +21 more
wiley   +1 more source

Comorbid Depression in Hospitalised Youth With Anorexia Nervosa: Characteristics, Correlates, and Impact on Weight Gain and Treatment Duration

open access: yesEuropean Eating Disorders Review, EarlyView.
ABSTRACT Objective Anorexia nervosa (AN) is associated with high rates of comorbidities. The impact of comorbid depression‐spectrum disorders (DSDs) in AN patients on the outcomes of inpatient treatment is insufficiently studied. Method Retrospective study of youth with AN (9–18 years), admission weight < 10th body mass index (BMI) percentile ...
Antonia Wiese   +5 more
wiley   +1 more source

Patient‐Reported Outcomes with Selpercatinib Among Patients with RET Fusion–Positive Non‐Small Cell Lung Cancer in the Phase I/II LIBRETTO‐001 Trial

open access: yesThe Oncologist, EarlyView., 2021
Abstract Background LIBRETTO‐001 is an ongoing, global, open‐label, phase I/II study of selpercatinib in patients with advanced or metastatic solid tumors. We report interim patient‐reported outcomes in patients with RET fusion–positive non‐small cell lung cancer (NSCLC).
Anna Minchom   +11 more
wiley   +1 more source

Resumption of Menses and Normalisation of Body Weight in Adolescents Undergoing Specialised Treatment for Anorexia Nervosa Inpatient or Outpatient Treatment

open access: yesEuropean Eating Disorders Review, EarlyView.
ABSTRACT Objective To predict resumption of menses (ROM) in patients with anorexia nervosa (AN). Method Females aged 9–17 years with AN, receiving inpatient multimodal treatment (IMT) or family‐based treatment (FBT) underwent assessments at baseline, 6‐month and 12‐month follow‐up (12FU).
Annika Woltmann   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy